Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription Articles published in J Immunol Retrieve available abstracts of 17 articles: HTML format

Single Articles

June 2026
1. PAL P, Wahi P, Paul S, Meitei HT, et al
   Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.
   J Immunol. 2026;215:vkag157.
   PubMed     Abstract available
   
   
   
2. MACY AM, Herrmann LM, Thornley EM, Adams AC, et al
   MHC class II on melanoma cells regulates the anti-tumor T cell response.
   J Immunol. 2026;215:vkag158.
   PubMed     Abstract available
   
   
   May 2026
3. TURNQUIST A, Javaid A, Wilkins OM, Kolling Iv F, et al
   PI3Kdelta inhibition alters CD8 T cell differentiation and reprograms the tumor microenvironment following adoptive immunotherapy.
   J Immunol. 2026;215:vkag108.
   PubMed     Abstract available
   
   
   March 2026
4. ONCUL S, Lee H, Singh S, Yee C, et al
   B cell depletion promotes melanoma tumor growth in a CD4+ T cell-dependent manner.
   J Immunol. 2026;215:vkag004.
   PubMed     Abstract available
   
   
   January 2026
5. HUANG P, Wang H, Guan X, Pu R, et al
   UTY coordinates with UTX to repress NK cell development and maturation in males.
   J Immunol. 2026;215:vkaf248.
   PubMed     Abstract available
   
   
   December 2025
6. GIRARD M, Yu T, Batista NV, Yeung KKM, et al
   STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity.
   J Immunol. 2025;214:3634-3646.
   PubMed     Abstract available
   
   
   October 2025
7. LIU M, Dhakal H, Li H, Murakami M, et al
   Prostaglandin D2 axis impairs immunity against melanoma via dendritic cells and gammadelta T cells in middle-aged mice.
   J Immunol. 2025 Oct 28:vkaf288. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. REN Y, Ballard DJ, Kumar A, Song AF, et al
   eEF2K promotes immune evasion in melanoma via Cyclin D1-mediated stabilization of PD-L1.
   J Immunol. 2025 Oct 16:vkaf278. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. REINARTZ DM, Escamilla-Rivera V, Shao M, Tribble SL, et al
   Impact of absent in melanoma 2 on head and neck squamous cell carcinoma development.
   J Immunol. 2025 Oct 3:vkaf224. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
10. TANEGASHIMA K, Esashi E, Ishida K, Kotaki A, et al
    CXCL14 is an essential modulator of TLR9 agonist-induced antitumor immune responses.
    J Immunol. 2025;214:2076-2086.
    PubMed     Abstract available
    
    
    September 2024
11. DIAMANTOPOULOS N, Li J, Bouchard A, Joumier L, et al
    ICOS-expressing Regulatory T Cells Influence the Composition of Antitumor CTL Populations.
    J Immunol. 2024;213:753-762.
    PubMed     Abstract available
    
    
    July 2024
12. ADAM K, Lipatova Z, Abdul Ghafoor Raja M, Mishra AK, et al
    Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity.
    J Immunol. 2024;213:7-13.
    PubMed     Abstract available
    
    
    December 2023
13. PEIL J, Vossen C, Bock F, Clahsen T, et al
    Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma.
    J Immunol. 2023 Dec 15:ji2300063. doi: 10.4049/jimmunol.2300063.
    PubMed     Abstract available
    
    
    
14. SINGH S, Xiao Z, Bavisi K, Roszik J, et al
    Corrections: IL-1alpha mediates innate and acquired resistance to immunotherapy in melanoma.
    J Immunol. 2023 Dec 13:ji2300689. doi: 10.4049/jimmunol.2300689.
    PubMed     Abstract available
    
    
    July 2023
15. THOMPSON B, Strange A, Amato CM, Hester-McCullough J, et al
    CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.
    J Immunol. 2023 Jul 19:ji2300250. doi: 10.4049/jimmunol.2300250.
    PubMed     Abstract available
    
    
    March 2023
16. ALAM MM, Gower T, Jiang M, Oppenheim JJ, et al
    A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice.
    J Immunol. 2023 Mar 22:ji2200371. doi: 10.4049/jimmunol.2200371.
    PubMed     Abstract available
    
    
    July 2021
17. CARLSON PM, Mohan M, Patel RB, Birstler J, et al
    Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice.
    J Immunol. 2021;207:720-734.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum